Literature DB >> 18075594

A viral microRNA functions as an orthologue of cellular miR-155.

Eva Gottwein1, Neelanjan Mukherjee, Christoph Sachse, Corina Frenzel, William H Majoros, Jen-Tsan A Chi, Ravi Braich, Muthiah Manoharan, Jürgen Soutschek, Uwe Ohler, Bryan R Cullen.   

Abstract

All metazoan eukaryotes express microRNAs (miRNAs), roughly 22-nucleotide regulatory RNAs that can repress the expression of messenger RNAs bearing complementary sequences. Several DNA viruses also express miRNAs in infected cells, suggesting a role in viral replication and pathogenesis. Although specific viral miRNAs have been shown to autoregulate viral mRNAs or downregulate cellular mRNAs, the function of most viral miRNAs remains unknown. Here we report that the miR-K12-11 miRNA encoded by Kaposi's-sarcoma-associated herpes virus (KSHV) shows significant homology to cellular miR-155, including the entire miRNA 'seed' region. Using a range of assays, we show that expression of physiological levels of miR-K12-11 or miR-155 results in the downregulation of an extensive set of common mRNA targets, including genes with known roles in cell growth regulation. Our findings indicate that viral miR-K12-11 functions as an orthologue of cellular miR-155 and probably evolved to exploit a pre-existing gene regulatory pathway in B cells. Moreover, the known aetiological role of miR-155 in B-cell transformation suggests that miR-K12-11 may contribute to the induction of KSHV-positive B-cell tumours in infected patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18075594      PMCID: PMC2614920          DOI: 10.1038/nature05992

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  30 in total

1.  Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells.

Authors:  Yan Zeng; Eric J Wagner; Bryan R Cullen
Journal:  Mol Cell       Date:  2002-06       Impact factor: 17.970

2.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing.

Authors:  Andrew Grimson; Kyle Kai-How Farh; Wendy K Johnston; Philip Garrett-Engele; Lee P Lim; David P Bartel
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

3.  Host immune system gene targeting by a viral miRNA.

Authors:  Noam Stern-Ginossar; Naama Elefant; Albert Zimmermann; Dana G Wolf; Nivin Saleh; Moshe Biton; Elad Horwitz; Zafnat Prokocimer; Mark Prichard; Gabriele Hahn; Debra Goldman-Wohl; Caryn Greenfield; Simcha Yagel; Hartmut Hengel; Yael Altuvia; Hanah Margalit; Ofer Mandelboim
Journal:  Science       Date:  2007-07-20       Impact factor: 47.728

4.  Protocols for expression and functional analysis of viral microRNAs.

Authors:  Eva Gottwein; Bryan R Cullen
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

5.  The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation.

Authors:  P H Olsen; V Ambros
Journal:  Dev Biol       Date:  1999-12-15       Impact factor: 3.582

6.  Regulation of the germinal center response by microRNA-155.

Authors:  To-Ha Thai; Dinis Pedro Calado; Stefano Casola; K Mark Ansel; Changchun Xiao; Yingzi Xue; Andrew Murphy; David Frendewey; David Valenzuela; Jeffery L Kutok; Marc Schmidt-Supprian; Nikolaus Rajewsky; George Yancopoulos; Anjana Rao; Klaus Rajewsky
Journal:  Science       Date:  2007-04-27       Impact factor: 47.728

7.  Systematic discovery of regulatory motifs in conserved regions of the human genome, including thousands of CTCF insulator sites.

Authors:  Xiaohui Xie; Tarjei S Mikkelsen; Andreas Gnirke; Kerstin Lindblad-Toh; Manolis Kellis; Eric S Lander
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-18       Impact factor: 11.205

8.  Requirement of bic/microRNA-155 for normal immune function.

Authors:  Antony Rodriguez; Elena Vigorito; Simon Clare; Madhuri V Warren; Philippe Couttet; Dalya R Soond; Stijn van Dongen; Russell J Grocock; Partha P Das; Eric A Miska; David Vetrie; Klaus Okkenhaug; Anton J Enright; Gordon Dougan; Martin Turner; Allan Bradley
Journal:  Science       Date:  2007-04-27       Impact factor: 47.728

9.  Identification of cellular genes targeted by KSHV-encoded microRNAs.

Authors:  Mark A Samols; Rebecca L Skalsky; Ann M Maldonado; Alberto Riva; M Cecilia Lopez; Henry V Baker; Rolf Renne
Journal:  PLoS Pathog       Date:  2007-05-11       Impact factor: 6.823

10.  Spatial preferences of microRNA targets in 3' untranslated regions.

Authors:  William H Majoros; Uwe Ohler
Journal:  BMC Genomics       Date:  2007-06-07       Impact factor: 3.969

View more
  309 in total

Review 1.  Current status of treatment for primary effusion lymphoma.

Authors:  Seiji Okada; Hiroki Goto; Mihoko Yotsumoto
Journal:  Intractable Rare Dis Res       Date:  2014-08

Review 2.  Virus-encoded microRNAs.

Authors:  Adam Grundhoff; Christopher S Sullivan
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

Review 3.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

4.  MicroRNA expression by an oncogenic retrovirus.

Authors:  Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-02       Impact factor: 11.205

5.  EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.

Authors:  Kasandra J Riley; Gabrielle S Rabinowitz; Therese A Yario; Joseph M Luna; Robert B Darnell; Joan A Steitz
Journal:  EMBO J       Date:  2012-03-30       Impact factor: 11.598

Review 6.  Noncoding RNPs of viral origin.

Authors:  Joan Steitz; Sumit Borah; Demian Cazalla; Victor Fok; Robin Lytle; Rachel Mitton-Fry; Kasandra Riley; Tasleem Samji
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

7.  Use of two novel approaches to discriminate between closely related host microRNAs that are manipulated by Toxoplasma gondii during infection.

Authors:  Gusti M Zeiner; John C Boothroyd
Journal:  RNA       Date:  2010-04-27       Impact factor: 4.942

8.  MicroRNAs control herpesviral dormancy.

Authors:  Xiufen Lei; Zhiqiang Bai; Fengchun Ye; Yufei Huang; Shou-Jiang Gao
Journal:  Cell Cycle       Date:  2010-04-01       Impact factor: 4.534

9.  Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.

Authors:  Johan H Gibcus; Lu Ping Tan; Geert Harms; Rikst Nynke Schakel; Debora de Jong; Tjasso Blokzijl; Peter Möller; Sibrand Poppema; Bart-Jan Kroesen; Anke van den Berg
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

10.  Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection.

Authors:  Zhiqiang Qin; Lu Dai; Michael Defee; Victoria J Findlay; Dennis K Watson; Bryan P Toole; Jennifer Cameron; Francesca Peruzzi; Keith Kirkwood; Chris Parsons
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.